Clavicular Ascension Stack: The Ultimate 12-Compound Looksmaxxing Protocol

Clavicular Ascension Stack: The Ultimate 12-Compound Looksmaxxing Protocol

Clavicular's original protocol — Retatrutide plus BPC-157 — changed how a generation of male researchers thought about peptide-based body optimization. But Clav himself has made clear that his basic stack is an entry point, not an endpoint. The Clavicular Ascension Stack is the evolution of that system: a comprehensive, 5-pillar protocol covering every major aesthetic variable simultaneously.

The word "Ascension" is deliberate. This is not incremental optimization. It is total transformation — a multi-system, multi-mechanism approach designed for researchers who have already run the fundamentals and are ready for the full protocol.

What Is the Clavicular Ascension Stack?

The Ascension Stack expands Clav's foundational fat-loss-and-recovery protocol into five distinct pillars, each targeting a different physiological system that contributes to the looksmaxxing aesthetic:

• Fat Loss — Retatrutide (triple-agonist maximum potency)
• Skin and Collagen — GHK-Cu + SNAP-8
• Recovery and Gut Protection — BPC-157
• Muscle and GH Axis — CJC-1295/Ipamorelin + IGF-1 LR3
• Metabolic Support — GLP-1 adjunct compounds

Running all five pillars simultaneously is the "ascension" — the point where fat loss, muscle development, skin quality, recovery capacity, and hormonal optimization are all being addressed in a single research protocol.

Why It's Called Ascension

Clavicular's framing of "ascension" draws on a concept familiar in looksmaxxing culture: the idea that aesthetic transformation is not a single intervention but a layered process of simultaneous system optimization. The original stack addresses the biggest variable — body fat. The Ascension Stack adds everything else.

The ascension framing also signals audience: this is not a beginner protocol. It is designed for researchers who have completed at least one full cycle on the basic Clavicular stack (Retatrutide + BPC-157), understand their individual responses to GLP-1 agonism, have established a baseline for peptide tolerance, and are now ready to layer additional compounds with different mechanism targets.

Pillar 1: Fat Loss — Retatrutide (GLP-3 R)

Retatrutide remains the cornerstone. As the world's only triple hormone receptor agonist — simultaneously targeting GIP, GLP-1, and glucagon receptors — it produces the most aggressive fat loss profile of any peptide in the research literature.

Why Retatrutide specifically: The glucagon receptor component is the differentiator. While Semaglutide suppresses appetite and Tirzepatide adds insulin sensitization, Retatrutide's glucagon agonism drives thermogenesis via brown adipose tissue activation and increases resting energy expenditure. TRIUMPH-4 Phase 3 data (December 2025, n=5,800+) showed 28.7% mean weight loss at 12mg over 68 weeks — an average of 71.2 lbs lost.

For the looksmaxxing aesthetic specifically, Retatrutide's liver fat reduction profile is remarkable: 82.4% liver fat reduction at 12mg vs. placebo +0.3% (Nature Medicine, 2024). Reduced visceral and hepatic fat produces the sharp facial definition, clavicular prominence, and angular body structure that is the target of looksmaxxing body composition work.

Available: GLP-3 R 10mg ($149.99), 15mg ($189.99), 30mg ($349.99), 60mg ($589.99)

Pillar 2: Skin and Collagen — GHK-Cu + SNAP-8

Skin quality is one of the most underrated variables in looksmaxxing. Body fat and muscle are visible at distance; skin quality determines how you look at close range — texture, pore size, expression lines, luminosity, tightness.

GHK-Cu (Copper Peptide) is the primary collagen driver. Naturally present in human plasma at ~200 ng/mL at age 20 but declining to under 80 ng/mL by age 60, GHK-Cu stimulates fibroblast collagen synthesis, promotes glycosaminoglycan production, activates the VEGF angiogenesis pathway, and modulates a gene expression cascade that affects over 32% of human genes involved in aging processes (Broad Institute analysis). Its dual mechanism — stimulating new collagen while simultaneously remodeling existing dermal matrix — makes it unique among skin peptides.

SNAP-8 (Acetyl Glutamyl Heptapeptide-3) attacks the anti-aging problem from a completely different angle. Rather than building collagen, it prevents the microexpressions that break it down. SNAP-8 is an octapeptide that modulates the SNARE protein complex — the neuronal machinery required for neurotransmitter release at the neuromuscular junction. By attenuating repetitive facial muscle contraction, it reduces the formation of dynamic expression lines. Studies have demonstrated up to 63% reduction in wrinkle depth with topical application, with effects complementary to (not competitive with) collagen-stimulating peptides.

Running GHK-Cu and SNAP-8 simultaneously means building the dermal architecture from below while protecting the skin surface from mechanical breakdown — a two-vector approach to anti-aging.

Available: GHK-Cu 50mg ($50.00), SNAP-8 ($45.00)

Pillar 3: Recovery and Gut Protection — BPC-157

BPC-157 (Body Protection Compound-157) is the Ascension Stack's systemic protection layer. Its three primary mechanisms — VEGF-dependent angiogenesis (VEGFR2 → PI3K → Akt → eNOS), VEGF-independent vascular stability (Src → caveolin-1 → eNOS), and FAK-paxillin pathway activation — make it relevant to every tissue being stressed by the other compounds in the stack.

In the context of Retatrutide, BPC-157 directly addresses GI side effects: its gastroprotective properties (derived from its origins in human gastric juice, where it was first isolated) counteract GLP-1-induced nausea and motility disruption. In the context of the GH axis compounds, BPC-157's growth hormone receptor upregulation properties may provide additive anabolic support.

BPC-157 is also stable in stomach acid for over 24 hours — unique among peptides — making it compatible with oral administration research protocols.

Available: BPC157 10mg ($59.99)

Pillar 4: Muscle and GH Axis — CJC-1295/Ipamorelin + IGF-1 LR3

The GH axis pillar addresses what fat loss alone cannot achieve: muscle fullness, frame development, and the hormonal environment for anabolic recovery.

CJC-1295/Ipamorelin is a synergistic GHRH analog + ghrelin mimetic combination. CJC-1295 stimulates pituitary GH release through the GHRH receptor while Ipamorelin amplifies GH pulse amplitude via ghrelin receptor agonism — without meaningfully affecting cortisol or prolactin. The combination maintains natural pulsatile GH release patterns rather than producing supraphysiological spikes.

IGF-1 LR3 (Long R3 Insulin-Like Growth Factor-1) acts downstream of GH in the anabolic cascade. Its 13-amino-acid N-terminal extension and arginine substitution at position 3 reduce IGF binding protein affinity, producing 3x greater bioavailability than native IGF-1. It activates the PI3K/Akt/mTOR signaling cascade — the central pathway for muscle protein synthesis and satellite cell activation. For looksmaxxing body composition, IGF-1 LR3 adds the muscle fullness that prevents the "skinny-fat" appearance that aggressive fat loss can create.

Available: CJC-1295/Ipamorelin ($89.99), IGF-1 LR3 1mg ($79.99)

Pillar 5: Metabolic Support

The fifth pillar is the systemic metabolic context — ensuring that the GH axis, inflammatory status, and recovery capacity all support the compound stack rather than work against it. BPC-157's nitric oxide modulation and anti-inflammatory properties contribute here, as does the insulin sensitivity improvements from Retatrutide's GIP and GLP-1 components.

Who Is the Ascension Stack For?

This protocol is designed for experienced researchers who have:

• Completed at least one full cycle of the basic Clavicular stack (Retatrutide + BPC-157)
• Established their GLP-1 tolerance and baseline dosing
• Reached a body fat percentage where GH axis and IGF-1 work is appropriate
• A research framework for monitoring compound interactions

It is not a starting point. Running Retatrutide, CJC/Ipamorelin, and IGF-1 LR3 simultaneously without prior experience with each category is a significant research variable that experienced researchers manage carefully.

How to Build Up to the Ascension Stack

Phase 1 — Foundation (weeks 1–8): Retatrutide + BPC-157. Establish GLP-1 tolerance, achieve initial body fat reduction, learn your individual GI response.

Phase 2 — Skin Layer (weeks 9–16): Add GHK-Cu and SNAP-8. Assess skin response. Both compounds are well-tolerated and have no meaningful interaction risks with GLP-1 agonists.

Phase 3 — Full Ascension (weeks 17+): Add CJC/Ipamorelin and IGF-1 LR3. By this stage, fat loss has advanced, the body composition foundation is established, and the GH axis compounds have the optimal metabolic environment to work in.

Products Available

Compound

Product

Price

Pillar

Retatrutide	GLP-3 R 15mg	$189.99	Fat Loss
GHK-Cu	GHK-Cu 50mg	$50.00	Skin
SNAP-8	SNAP-8	$45.00	Skin
BPC-157	BPC157 10mg	$59.99	Recovery
CJC/Ipamorelin	CJC-1295/Ipamorelin No DAC	$89.99	GH Axis
IGF-1 LR3	IGF-1 LR3 1mg	$79.99	GH Axis
Full Stack	$514.96	All 5 Pillars

Research Disclaimer

All compounds in the Clavicular Ascension Stack are research peptides not approved for human use. Retatrutide is currently in Phase 3 clinical trials (TRIUMPH program). CJC-1295/Ipamorelin and IGF-1 LR3 are for research use only. This content is for informational and educational purposes. Consult a qualified healthcare professional before considering any research peptide protocol.